Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
670 studies found for:    STEM CELLS TEXAS
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)
Condition: Coronary Artery Disease
Interventions: Biological: Stem Cell Therapy;   Other: Control (plasma)
2 Completed
Has Results
Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)
Condition: Ischemic Cardiomyopathy
Interventions: Device: Intramyocardial Injection of stem cells via NOGA Mapping;   Other: Control, then Stem Cell Therapy
3 Active, not recruiting Exercise and NutraStem (NT-020): Effects on Stem Cells
Condition: Adult Stem Cell Proliferation
Interventions: Drug: NutraStem;   Drug: Placebo
4 Recruiting Incidence and Factors Associated With the Development and Severity of Oral Mucositis
Condition: Peripheral Blood Stem Cell Transplantation
Intervention: Other: Mucositis and nutritional assessments
5 Active, not recruiting Safety and Effectiveness of Banked Cord Blood or Bone Morrow Stem Cells in Children With Cerebral Palsy (CP).
Condition: Cerebral Palsy
Interventions: Biological: Autologous Stem Cells;   Other: Saline Infusion (Placebo)
6 Completed
Has Results
Comparative Trial of Cryotherapy Versus Caphosol Versus Saline Solution Mouth Washes for the Prevention of Oral Mucositis in Patients With Multiple Myeloma Undergoing Hematopoietic Stem Cell Transplantation
Conditions: Mucositis;   Multiple Myeloma
Interventions: Drug: 0.9% Sodium Chloride irrigation solution;   Other: Cryotherapy (ice chips);   Device: Calcium phosphate (Caphosol) Ca2+/PO43- mouth rinse
7 Not yet recruiting Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Biological: Allogeneic bone marrow-derived MSCs
8 Recruiting Aging Mammary Stem Cells and Breast Cancer Prevention
Condition: Cancer of Breast
Intervention: Drug: Rapamycin
9 Recruiting Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
Conditions: Stem Cell Transplant;   Allogeneic
Intervention: Device: CliniMACS CD34 Reagent system
10 Terminated Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO
Condition: Thalassemia
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: Campath 1H;   Drug: Cyclophosphamide;   Drug: MESNA
11 Enrolling by invitation Autologous Stem Cell Study for Adult TBI (Phase 2b)
Conditions: Brain Injuries, Traumatic;   Brain Injuries, Acute;   TBI (Traumatic Brain Injury)
Interventions: Biological: Placebo Infusion;   Biological: Autologous BMMNC Infusion
12 Terminated Autologous Stem Cells for Spinal Cord Injury (SCI) in Children
Condition: Spinal Cord Injury
Intervention: Biological: bone marrow progenitor cells (BMPC) autologous transplantation
13 Not yet recruiting A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant Recipients
Conditions: Hematologic Diseases;   Stem Cell Transplants
Intervention: Drug: PUL-042
14 Completed Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in Children
Condition: Traumatic Brain Injury
Intervention: Procedure: Autologous bone marrow precursor cell harvest and transplant
15 Terminated
Has Results
T-Reg Cell Kinetics, Stem Cell Transplant, REGALE
Conditions: Leukemia;   Hodgkin Lymphoma;   Non Hodgkin Lymphoma;   Myeloproliferative Disorders
Interventions: Drug: ARA C;   Drug: Cyclophosphamide;   Drug: MESNA;   Radiation: Total Body Irradiation (TBI);   Biological: Campath-1h;   Procedure: Stem Cell Infusion
16 Terminated Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Chronic Lymphocytic Leukemia;   Chronic Myelogenous Leukemia;   Hodgkins Disease;   Non-Hodgkins Lymphoma;   Aplastic Anemia;   Multiple Myeloma;   Myelodysplastic Syndrome
Interventions: Drug: Busulfan;   Drug: Clofarabine;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cytarabine
17 Completed
Has Results
Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study)
Conditions: Chronic Ischemic Heart Disease;   Left Ventricular Dysfunction;   Angina;   Ischemic Cardiomyopathy
Interventions: Biological: Adult stem cells;   Biological: Placebo
18 Terminated
Has Results
T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE
Conditions: Leukemia;   Cancer;   Lymphoma;   Lymphoma, Hodgkin;   Lymphoma, Non-Hodgkin
Interventions: Drug: Ara C;   Drug: Mesna;   Drug: Cyclophosphamide;   Radiation: TBI-Total Body Irradiation
19 Terminated
Has Results
Stem Cell Transplant for Hematologic Diseases
Condition: Hematologic Malignancies
Interventions: Biological: Campath 1H;   Drug: Fludarabine;   Procedure: Stem Cell Transplant;   Radiation: Total Body Irradiation (TBI);   Drug: FK506 (Tacrolimus) or Cyclosporine
20 Completed
Has Results
Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study)
Condition: Left Ventricular Dysfunction
Interventions: Biological: Adult stem cells;   Biological: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.